Results 51 to 60 of about 5,298,732 (170)

P037 Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis? [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2019
Career situation of first and presenting author Resident. Introduction The current EULAR-2010 diagnostic criteria for Rheumatoid Arthritis (RA) relies heavily on the presence of auto-antibodies. So far only anti-citrullinated peptide antibody (ACPA) or rheumatoid factor (RF) are accounted for however, novel auto-reactivities have been described ...
F Ponchel   +4 more
openaire   +1 more source

Identification of serum anti-carbamylated protein antibodies in rheumatoid arthritis patients with periodontitis: A pilot study

open access: yes, 2022
Objectives: In chronic diseases such as rheumatoid arthritis (RA), carbamylation may cause the production of autoantibodies such as the anti-carbamylated protein antibody (anti-CarP) and protein malfunctioning. However, its relation to periodontitis (PD)
Venu Gopal, Shruthi
core   +1 more source

Carbamylation/citrullination of IgG Fc in bronchiectasis, established RA with bronchiectasis and RA smokers: a potential risk factor for disease

open access: yesERJ Open Research, 2017
Bronchiectasis (BR) and smoking are risk factors for rheumatoid arthritis (RA) development. The mechanisms by which smoking and BR trigger RA are unknown, but are associated with concurrent rheumatoid factor (RF) and anti-cyclic citrullinated peptide ...
David Hutchinson   +4 more
doaj   +1 more source

Identification of a Novel Serological Marker in Seronegative Rheumatoid Arthritis Using the Peptide Library Approach

open access: yesFrontiers in Immunology, 2021
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation mainly affecting the joints leading to cartilage and bone destruction.
Caterina Bason   +10 more
doaj   +1 more source

AB0512 ANTI-CARBAMYLATED PROTEIN ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS: ARE THEY USEFUL? [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2019
Background: Anti-carbamylated protein antibodies (anti-CarP) have been described not only in Rheumatoid arthritis but in other systemic autoimmune diseases. Recently, they have been reported in different cohorts of Systemic Lupus Erythematosus (SLE) with a prevalence of 9-28% (1-4). Anti-CarP have been proposed as a marker of erosive arthitis in SLE(4)
Rajesh Kumar   +5 more
openaire   +1 more source

Anti-carbamylated protein antibodies positivity and disease activity in Hispanic patients with established rheumatoid arthritis: an observational study [PDF]

open access: yes, 2021
Objectives We aimed to determine the prevalence of anti-carbamylated protein (anti-CarP) antibodies in Mexican Hispanics with established rheumatoid arthritis (RA) and to assess their relationship with disease activity.
Loredo-Alanis, S.A.   +17 more
core   +1 more source

Neuropathophysiological potential of Guillain-Barré syndrome anti-ganglioside-complex antibodies at mouse motor nerve terminals [PDF]

open access: yes, 2011
Objectives:  Anti-ganglioside antibodies are present in approximately half of Guillain–Barré syndrome (GBS) patients. Recently, it has been shown that a considerable proportion of these patients has serum antibodies against antigenic epitopes formed by a
Susumu Kusunoki   +32 more
core   +1 more source

Anti-neurofascin antibodies [PDF]

open access: yes, 2012
Neurofascin (NF) is a cell-adhesion molecule that is found at the nodes of Ranvier. The 186 kDa isoform of neurofascin (NF186) is expressed on the axon in the exposed node, and the 155 kDa isoform (NF155) is expressed on myelinating glia at the ...
Ng, King Man
core   +1 more source

Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations

open access: yesArthritis Research & Therapy, 2023
Background Rheumatoid arthritis (RA) occurs across the globe in different ethnic populations. Most RA patients harbor anti-modified protein antibodies (AMPA); however, it is unclear whether differences exist in autoantibody responses at different ...
Emma C. de Moel   +10 more
doaj   +1 more source

IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study. [PDF]

open access: yes, 2015
IgG anti-apolipoprotein A-1 (IgG anti-apoA-1) antibodies are present in patients with systemic lupus erythematosus (SLE) and may link inflammatory disease activity and the increased risk of developing atherosclerosis and cardiovascular disease (CVD) in ...
Davari, M   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy